AR045229A1 - 6-(2,2,2-trifluoroetilamino)-7 cloro-2,3,4,5- tetrahidro-1h- benzo [d] azepina como agonista del receptor 5- ht2c - Google Patents
6-(2,2,2-trifluoroetilamino)-7 cloro-2,3,4,5- tetrahidro-1h- benzo [d] azepina como agonista del receptor 5- ht2cInfo
- Publication number
- AR045229A1 AR045229A1 ARP040102845A ARP040102845A AR045229A1 AR 045229 A1 AR045229 A1 AR 045229A1 AR P040102845 A ARP040102845 A AR P040102845A AR P040102845 A ARP040102845 A AR P040102845A AR 045229 A1 AR045229 A1 AR 045229A1
- Authority
- AR
- Argentina
- Prior art keywords
- ht2c
- benzo
- tetrahydro
- trifluoroethylamine
- azepin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
La presente proporciona un 7-cloro-6-(2,2,2-trifluoretilamino)-2,3,4,5-tetrahidro-1H-benzo[d]azepina de fórmula (1), o una sal del mismo farmacéuticamente aceptable, y su uso como agonista selectivo de 5-HT2C para el tratamiento de trastornos asociados con los receptores 5-HT2C, incluyendo obesidad, trastorno obsesivo/compulsivo, ansiedad y depresión.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49420803P | 2003-08-11 | 2003-08-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045229A1 true AR045229A1 (es) | 2005-10-19 |
Family
ID=34215860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102845A AR045229A1 (es) | 2003-08-11 | 2004-08-09 | 6-(2,2,2-trifluoroetilamino)-7 cloro-2,3,4,5- tetrahidro-1h- benzo [d] azepina como agonista del receptor 5- ht2c |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060264418A1 (es) |
EP (1) | EP1656352A1 (es) |
JP (1) | JP2007502272A (es) |
CN (1) | CN1832926A (es) |
AR (1) | AR045229A1 (es) |
AU (1) | AU2004267027A1 (es) |
BR (1) | BRPI0413342A (es) |
CA (1) | CA2532020A1 (es) |
MX (1) | MXPA06001647A (es) |
TW (1) | TW200510324A (es) |
WO (1) | WO2005019180A1 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2248524A3 (en) | 2004-08-25 | 2011-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
PT1924561E (pt) | 2005-09-01 | 2013-01-16 | Lilly Co Eli | Módulo de cabeça de impressão tendo uma fiada solta e controlador de impressora para lhe fornecer dados |
EP1924578B1 (en) | 2005-09-01 | 2013-11-06 | Eli Lilly And Company | 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
AU2006287160B2 (en) | 2005-09-01 | 2012-04-05 | Eli Lilly And Company | 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
US7994163B2 (en) * | 2005-09-01 | 2011-08-09 | Eli Lilly And Company | 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
US7897595B2 (en) | 2006-05-26 | 2011-03-01 | Forest Laboratories Holdings Limited | Pyridoazepine derivatives |
BRPI0715160A2 (pt) | 2006-08-08 | 2013-06-11 | Sanofi Aventis | imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso |
EP2216023A4 (en) | 2007-11-15 | 2013-03-13 | Takeda Pharmaceutical | CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF |
WO2009111004A1 (en) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
EP2470552B1 (en) | 2009-08-26 | 2013-11-13 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
WO2012030957A2 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-ht2c agonists |
MX2013002430A (es) * | 2010-09-01 | 2013-07-22 | Arena Pharm Inc | Formas de dosis de disolucion de rápida de agonistas de 5-ht2c. |
CA2808909A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
CN103347523A (zh) | 2010-09-01 | 2013-10-09 | 艾尼纳制药公司 | 向具有肾损伤的个体给药氯卡色林 |
KR20180118801A (ko) | 2010-09-01 | 2018-10-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태 |
WO2012030953A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683698B1 (de) | 2011-03-08 | 2017-10-04 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN103145619A (zh) * | 2012-06-15 | 2013-06-12 | 史慎德 | 7-氯-6-苯磺酰氨基-2,3,4,5-四氢-1H-苯并[d]氮杂*的制备 |
BR112015007779A2 (pt) | 2012-10-09 | 2017-07-04 | Arena Pharm Inc | célula de fluxo de permeabilidade e sistema de condutância hidráulica |
WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
EP3860996A4 (en) | 2018-10-02 | 2022-08-31 | Northwestern University | BETA-CARBOLINES AS POSITIVE ALLOSTERIC MODULATORS OF HUMAN SEROTONIN RECEPTOR 2C (5-HT2C) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH498122A (de) * | 1968-02-09 | 1970-10-31 | Geigy Ag J R | Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates |
FR2358151A1 (fr) * | 1976-03-31 | 1978-02-10 | Roussel Uclaf | Nouvelles benzazepines et leurs sels, procede de preparation et application a titre de medicaments |
JPH06508352A (ja) * | 1991-06-21 | 1994-09-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 門脈圧亢進症および片頭痛の治療用のテトラヒドロベンズアゼピン誘導体の使用 |
WO2002074746A1 (fr) * | 2001-03-16 | 2002-09-26 | Yamanouchi Pharmaceutical Co., Ltd. | Derives de benzazepine |
AU2002346507A1 (en) * | 2001-11-28 | 2003-06-10 | Pharmacia And Upjohn Company | Benzazepine derivatives and their use as 5-ht ligands |
US6953787B2 (en) * | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
GB0212399D0 (en) * | 2002-05-29 | 2002-07-10 | Glaxo Group Ltd | Compounds |
-
2004
- 2004-07-23 TW TW093122164A patent/TW200510324A/zh unknown
- 2004-07-30 EP EP04756905A patent/EP1656352A1/en not_active Withdrawn
- 2004-07-30 WO PCT/US2004/022299 patent/WO2005019180A1/en not_active Application Discontinuation
- 2004-07-30 CA CA002532020A patent/CA2532020A1/en not_active Abandoned
- 2004-07-30 MX MXPA06001647A patent/MXPA06001647A/es not_active Application Discontinuation
- 2004-07-30 CN CNA2004800228703A patent/CN1832926A/zh active Pending
- 2004-07-30 JP JP2006523190A patent/JP2007502272A/ja not_active Withdrawn
- 2004-07-30 AU AU2004267027A patent/AU2004267027A1/en not_active Abandoned
- 2004-07-30 US US10/568,136 patent/US20060264418A1/en not_active Abandoned
- 2004-07-30 BR BRPI0413342-0A patent/BRPI0413342A/pt not_active Application Discontinuation
- 2004-08-09 AR ARP040102845A patent/AR045229A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20060264418A1 (en) | 2006-11-23 |
CN1832926A (zh) | 2006-09-13 |
AU2004267027A1 (en) | 2005-03-03 |
EP1656352A1 (en) | 2006-05-17 |
MXPA06001647A (es) | 2006-04-28 |
BRPI0413342A (pt) | 2006-10-10 |
TW200510324A (en) | 2005-03-16 |
WO2005019180A1 (en) | 2005-03-03 |
JP2007502272A (ja) | 2007-02-08 |
CA2532020A1 (en) | 2005-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR045229A1 (es) | 6-(2,2,2-trifluoroetilamino)-7 cloro-2,3,4,5- tetrahidro-1h- benzo [d] azepina como agonista del receptor 5- ht2c | |
UA85699C2 (en) | 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists | |
GB0504828D0 (en) | Therapeutic agents | |
BRPI0309303B8 (pt) | compostos moduladores de receptores de 5ht2c, composição farmacêutica, e uso dos referidos compostos | |
PA8597301A1 (es) | Derivados de imidazol-4-il-etinil-piridina | |
AR028824A1 (es) | Compuestos antagonistas npy-5 y su uso en la manufactura de medicamentos. | |
UY28150A1 (es) | Agentes terapeuticos | |
PE20010630A1 (es) | Uso de una composicion antialergica para el tratamiento de trastornos mentales | |
MX2007007220A (es) | Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos. | |
NO20032253D0 (no) | Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer | |
ATE438627T1 (de) | 6-substituierte- 2,3,4,5-tetrahydro-1h- benzoädüazepine als 5-ht2c-rezeptoragonisten | |
MX2008002180A (es) | 2,3,4,5-tetrahidro-1h-benzo[d]azepinas 6-sustituidas como agonistas de receptor 5-ht2c. | |
ATE401307T1 (de) | N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ECSP088094A (es) | Antagonistas y agonistas de piperazin-piperidina del receptor 5-ht1a | |
GT201000179A (es) | "antagonistas del receptor mineralcorticoide y metodos de uso" | |
BRPI0316895B8 (pt) | composto, processo para a preparação do composto, composição farmacêutica e uso do composto | |
DE60014339T8 (de) | Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren | |
WO2004082584A3 (en) | 5ht2c receptor antagonists in the treatment of schizophrenia | |
CL2003001360A1 (es) | Compuestos derivados de pirazol, composicion farmaceutica, agonistas o antagonistas selectivos dl receptor cck-1, utiles para el tratamiento de trastornos gastrointestinales y del sistema nervioso central. | |
PT1381615E (pt) | Derivados antidepressivos de indoletetra-hidropiridina de 2,3-dihidro-7h-[1,4]dioxino[2,3-e]indole | |
DOP2004000972A (es) | 6-(2,2,2-trifluoroetilamino)-7-cloro-2,3,4,5-tetrahidro 1h-benzo[d] azepina como agonista del receptor 5-ht2c | |
AR041470A1 (es) | Compuestos de pirrolo (1,2 - b) piridazina y sus usos | |
DE602004012318D1 (de) | Crf-rezeptorantagonisten und diese betreffende verfahren | |
MXPA05010833A (es) | Compuestos de pirrolo[1,2-b]piridazina y sus usos. | |
WO2000010973A3 (en) | Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |